Enter a 10-digit HTS line, the country of origin and the entry date to see the base rate, 301 / 232 / 201 / 338 additional duties, AD/CVD deposits, PGA flags and other requirements, with a confirmed total and a maximum.
Don't know the U.S. import tariff code? Classify a product →
Nothing conditional to confirm: file at the base rate plus the additions that apply.
China: Column 1 rate + 12.5% additional
8-digit subheading 4803.00.20 is on L3
may-be-required only · ACE valid to 2039-12-31
no entered value: rates and limits only
Period 2026-10-01 – 2027-09-30 · 91 FR 48398 (2026-07-31, Doc. 2026-15530, FY2027)
Chinese origin: the UFLPA presumption is triggered through the supply chain (Xinjiang inputs / Entity List), not by country of origin; the origins with the most CBP denials are MY / VN / TH.
Not in a UFLPA priority sector, and no WRO or Finding applies to this origin. The UFLPA presumption still applies through the supply chain (Xinjiang content or listed entities).
No requirement matched to this HTS line (general requirements below).
Before arrival: Foreign facility registration (FEI / registration number); designate the FSVP importer (name + DUNS); submit and confirm Prior Notice in advance (road 2 hours / air and rail 4 hours / ocean 8 hours)
At entry: FDA / FOO message set: product code, manufacturer, shipper, grower, country of production, FSVP importer DUNS, AofC codes; PN confirmation number
Disclaim: FD1 / FD3: only code A (B rejected since 2020-04-18); FD2 / FD4 cannot be disclaimed
If missing: Missing PN → refusal under 801(m) / hold at port; missing 801(a) data → entry rejected / FDA hold
2025–26: PN final rule effective 2025-10-27 (resubmit within 10 days after refusal; mail tracking number from 2026-10-01); FSMA 204 traceability compliance postponed to 2028-07-20; Supplemental Guide v2.5.13 (2025-09)
https://www.fda.gov/industry/import-basics/harmonized-tariff-schedule-and-fd-flags · Verification H
Before arrival: Drug establishment registration and listing (NDC), NDA / ANDA; importer FEI / DUNS
At entry: FDA / DRU message set: product code, manufacturer, FDA importer, intended-use code (required), DA / DLS / REG AofC
Disclaim: FD1: only code A; FD2 cannot be disclaimed
If missing: Entry rejected / FDA hold
https://www.fda.gov/media/186046/download · Verification H
Before arrival: Establishment registration and device listing; 510(k) / PMA number; initial importer registration
At entry: DEV / DFE / LST AofC required; PM# (510(k) / PMA); intended-use code
Disclaim: FD1: only code A; FD2 cannot be disclaimed
If missing: Entry rejected / hold
https://www.fda.gov/media/186046/download · Verification H
Before arrival: BLN / STN license, establishment registration, HCT/P registration
At entry: BIO message set: BLN/STN, REG, IND, HCT/HRN AofC
Disclaim: FD1: only code A; FD2 cannot be disclaimed
If missing: Entry rejected / hold
https://www.fda.gov/media/186046/download · Verification H
Before arrival: MoCRA facility registration / product listing (FEI)
At entry: Product code, manufacturer, FDA importer, country of production
Disclaim: FD1: only code A; FD2 cannot be disclaimed
If missing: Entry rejected / hold
https://www.fda.gov/media/186046/download · Verification H
Before arrival: Product report / accession number; FDA 2877 declaration code
At entry: RA1–RA7 / RB / RC / RD AofC; product name
Disclaim: FD1: only code A; FD2 cannot be disclaimed
If missing: Entry rejected / hold
https://www.fda.gov/media/186046/download · Verification H
Before arrival: Manufacturer registration / listing; marketing authorization (PMTA / SE) status
At entry: Product name, intended-use code; PMT / SE / EXE AofC
Disclaim: FD1: only code A; FD2 cannot be disclaimed
If missing: Entry rejected / hold
https://www.fda.gov/media/186046/download · Verification H
Before arrival: NADA / ANADA, drug listing (NDC), establishment registration
At entry: VME message set: NDC, REG, VAN/VNA AofC
Disclaim: FD1: only code A; FD2 cannot be disclaimed
If missing: Entry rejected / hold
https://www.fda.gov/media/186046/download · Verification H
| A | B | Relation | Rule | Basis |
|---|---|---|---|---|
| FL301 | BASE | stack | Additive to Column 1; EU/TW net-of-MFN to 10%, JP/KR/CH to 12.5% | HTSUS Rev.21 note 52(a), 52(k) |
| FL301 | CN301 | stack | Stacks with China 301 | note 52(a) |
| FL301 | FTA | note | Preference claims do not exempt, except USMCA duty-free (9903.05.93/.94) and CAFTA-DR textiles (9903.05.95) | note 52(a), (g)–(i) |
| FL301 | CH98 | note | Chapter 98 exempt except 9802.00.40/.50/.60 (value of repairs) and 9802.00.80 (value less U.S. content) | note 52(a) |
| CN301 | BASE | stack | Additive to Column 1 | note 20(a)/(c)/(e)/(g)/(r); note 31(a) |
| CN301 | FTA | note | Preference claims do not exempt | note 20 / note 31(a) |
| CN301 | CH98 | note | Chapter 98 exempt except 9802.00.40/.50/.60/.80 | note 20 paragraphs / note 31(a) |
| CN301 | CN301 | note | Four-year-review products removed from note 20 lists (no double 25%); chassis and STS cranes stack with maritime 301 from 2026-11-10 | Rev.21 note 20 / 31 comparison; note 31(k)/(l) |
Compiled from the HTSUS, the Federal Register, CBP CSMS messages and ACE reports as a classification and compliance reference, not legal advice; file according to current CBP/ACE guidance.